These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1134 related articles for article (PubMed ID: 12052040)
21. Endocannabinoids in cognition and dependence. Lichtman AH; Varvel SA; Martin BR Prostaglandins Leukot Essent Fatty Acids; 2002; 66(2-3):269-85. PubMed ID: 12052042 [TBL] [Abstract][Full Text] [Related]
22. The endocannabinoid system as a target for novel anxiolytic and antidepressant drugs. Gaetani S; Dipasquale P; Romano A; Righetti L; Cassano T; Piomelli D; Cuomo V Int Rev Neurobiol; 2009; 85():57-72. PubMed ID: 19607961 [TBL] [Abstract][Full Text] [Related]
23. Role of endogenous cannabinoids in synaptic signaling. Freund TF; Katona I; Piomelli D Physiol Rev; 2003 Jul; 83(3):1017-66. PubMed ID: 12843414 [TBL] [Abstract][Full Text] [Related]
24. Interaction of the cannabinoid and opioid systems in the modulation of nociception. Welch SP Int Rev Psychiatry; 2009 Apr; 21(2):143-51. PubMed ID: 19367508 [TBL] [Abstract][Full Text] [Related]
25. Cannabinoids in the treatment of pain and spasticity in multiple sclerosis. Smith PF Curr Opin Investig Drugs; 2002 Jun; 3(6):859-64. PubMed ID: 12137404 [TBL] [Abstract][Full Text] [Related]
26. Cannabinoid-mediated modulation of neuropathic pain and microglial accumulation in a model of murine type I diabetic peripheral neuropathic pain. Toth CC; Jedrzejewski NM; Ellis CL; Frey WH Mol Pain; 2010 Mar; 6():16. PubMed ID: 20236533 [TBL] [Abstract][Full Text] [Related]
27. Cannabinoids for the treatment of neuropathic pain: clinical evidence. Ashton JC; Milligan ED Curr Opin Investig Drugs; 2008 Jan; 9(1):65-75. PubMed ID: 18183533 [TBL] [Abstract][Full Text] [Related]
28. [The cannabinoid system and pain: a new therapeutic avenue?]. Desroches J; Beaulieu P Rev Med Suisse; 2008 Jun; 4(162):1505-6, 1508-10, 1512-3. PubMed ID: 18649597 [TBL] [Abstract][Full Text] [Related]
30. Selective activation of cannabinoid CB(2) receptors suppresses spinal fos protein expression and pain behavior in a rat model of inflammation. Nackley AG; Makriyannis A; Hohmann AG Neuroscience; 2003; 119(3):747-57. PubMed ID: 12809695 [TBL] [Abstract][Full Text] [Related]
31. The pharmacology of cannabinoid receptors and their ligands: an overview. Pertwee RG Int J Obes (Lond); 2006 Apr; 30 Suppl 1():S13-8. PubMed ID: 16570099 [TBL] [Abstract][Full Text] [Related]
32. Pharmacology of cannabinoids. Grotenhermen F Neuro Endocrinol Lett; 2004; 25(1-2):14-23. PubMed ID: 15159677 [TBL] [Abstract][Full Text] [Related]
34. Local peripheral antinociceptive effects of 14-O-methyloxymorphone derivatives in inflammatory and neuropathic pain in the rat. Obara I; Makuch W; Spetea M; Schütz J; Schmidhammer H; Przewlocki R; Przewlocka B Eur J Pharmacol; 2007 Mar; 558(1-3):60-7. PubMed ID: 17204264 [TBL] [Abstract][Full Text] [Related]
37. Multiple roles for the endocannabinoid system during the earliest stages of life: pre- and postnatal development. Fride E J Neuroendocrinol; 2008 May; 20 Suppl 1():75-81. PubMed ID: 18426504 [TBL] [Abstract][Full Text] [Related]
38. The gastrointestinal pharmacology of cannabinoids: an update. Coutts AA; Izzo AA Curr Opin Pharmacol; 2004 Dec; 4(6):572-9. PubMed ID: 15525546 [TBL] [Abstract][Full Text] [Related]
39. The future of cannabinoids as analgesic agents: a pharmacologic, pharmacokinetic, and pharmacodynamic overview. McCarberg BH; Barkin RL Am J Ther; 2007; 14(5):475-83. PubMed ID: 17890938 [TBL] [Abstract][Full Text] [Related]